Form 4: Barfresh Food Group CEO Riccardo Delle Coste Reports Stock Option Grant and Beneficial Ownership
SEC Form 4 Filing
Riccardo Delle Coste, CEO of Barfresh Food Group Inc., reports the acquisition of stock options and updates to his beneficial ownership of company stock.
Summary
- Riccardo Delle Coste, the CEO of Barfresh Food Group Inc. (BRFH), filed a Form 4 detailing changes in his beneficial ownership.
- The report includes the grant of stock options and the reporting of direct and indirect ownership of common stock.
- Delle Coste directly owns 6,591 shares of common stock and indirectly owns 6,782 shares through the Delle Coste Family Trust and 1,642,022 shares through RD Capital Holdings Pty Ltd.
- He also holds various stock options with different exercise prices and expiration dates, totaling 19,231 shares each for several grants, along with 75,029 warrants.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing related to stock options and ownership, with no inherently positive or negative implications.
Positives
- The CEO's stock option grant could align his interests with those of shareholders, incentivizing him to improve company performance.
- The vesting schedule of the options (equal amounts annually over three years) encourages long-term commitment.
Management Comments
- Options vest in equal amounts annually over three years beginning on the first anniversary of the grant date.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- Shareholders gain insight into the CEO's stake in the company.
- Employees may be affected by the stock option grants if they are part of a broader employee compensation plan.
Key Dates
| Date | Description |
|---|---|
| 05/27/2017 | Stock option grant with exercise price $7.93, expiring 05/27/2024. |
| 11/25/2017 | Stock option grant with exercise price $9.36, expiring 11/25/2024. |
| 04/27/2018 | Stock option grant with exercise price $9.36, expiring 04/27/2025. |
| 07/26/2019 | Stock option grant with exercise price $6.76, expiring 07/26/2026. |
| 05/20/2020 | Stock option grant with exercise price $5.85, expiring 05/20/2027. |
| 03/31/2020 | Warrant grant with exercise price $3.51, expiring 03/30/2025. |
| 04/25/2021 | Stock option grant with exercise price $4.94, expiring 04/25/2028. |
| 04/27/2022 | Stock option grant with exercise price $5.72, expiring 04/27/2029. |
| 04/27/2023 | Stock option grant with exercise price $6.79, expiring 04/27/2030. |
| 04/27/2024 | Stock option grant with exercise price $1.33, expiring 04/27/2031. |
| 04/29/2024 | Earliest transaction date reported; stock option grant with exercise price $1.57, expiring 04/29/2032. |
| 05/01/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.